Self-protection of individual CD4+ T cells against R5 HIV-1 infection by the synthesis of anti-viral CCR5 ligands.
It is well established that paracrine secretion of anti-viral CCR5 ligands by CD8+ and CD4+ T cells can block the infection of activated CD4+ T cells by R5 and dual-tropic isolates of HIV-1. By contrast, because CD4+ T cells can be infected by HIV-1 and at least some subsets secrete anti-viral CCR5...
Κύριοι συγγραφείς: | Yongjun Guan, Sayed Abdelwahab, Roberta Kamin-Lewis, Anthony L DeVico, George K Lewis |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Public Library of Science (PLoS)
2008-01-01
|
Σειρά: | PLoS ONE |
Διαθέσιμο Online: | http://europepmc.org/articles/PMC2567041?pdf=render |
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
The first structure of HIV-1 gp120 with CD4 and CCR5 receptors
ανά: Yongjun Guan
Έκδοση: (2019-01-01) -
CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape
ανά: Gero Hütter, κ.ά.
Έκδοση: (2015-07-01) -
CD4-Induced epitopes in HIV infection
ανά: Hudacik Lauren, κ.ά.
Έκδοση: (2006-12-01) -
Gene editing CCR5 in HIV subjects CD4 T cells
ανά: D. Ando
Έκδοση: (2015-12-01) -
People with HIV have higher percentages of circulating CCR5+ CD8+ T cells and lower percentages of CCR5+ regulatory T cells
ανά: Louise E. van Eekeren, κ.ά.
Έκδοση: (2022-07-01)